Abstract:
The present invention provides a planting container capable of sufficiently and stably supply planting water to a rhizosphere where roots of a plant grow, securing as large a space as possible for the rhizosphere, and further accelerating the growth of the stem or leaves of the plant. The planting container comprises a planting container body 1 including a planting space 2 having an opening at a front portion thereof to allow a plant to grow, a reservoir 8 for planting water that is provided in a lower part of the planting space 2, and a water-absorbing planting bed placed within the planting space 2 with a bottom portion thereof being positioned in the reservoir 8 for absorbing planting water retained in the reservoir 8 to cultivate the plant, wherein the container further comprises a receiving surface 10 for receiving the planting bed within the planting space 2 formed as an inclined surface that is raised progressively toward the opening and is lowered progressively away from the opening.
Abstract:
The present invention relates to a therapeutic agent for irritable bowel syndrome of diarrhea type, ulcerative colitis, visceral pain or abdominal pain, which contains a compound of the following formula and which has 5-HT7 receptor antagonistic effect or an analogue thereof; and this therapeutic agent has an excellent therapeutic effect and a high safety:
Abstract:
To construct the apparatus convenient in the respects of both the installing space and movability of a culturing vessel. The plant culturing vessel includes a culturing vessel 1 capable of culturing a plant therein, a tank 4 capable of reserving a culturing liquid 3 for the plant therein, a communication passage 26 communicating between the vessel 1 and the tank 4, and a pump P incorporated in the communication passage 26, the pump P being capable of feeding the liquid 3 reserved in the tank 4 to the plant culturing vessel 1. The tank 4 includes a support portion 9 capable of supporting the culturing vessel 1 upwardly of the tank 4. The communication passage 26 is disposed along the support portion. The pump P is provided integrally with the tank.
Abstract:
The present invention relates to a therapeutic agent for irritable bowel syndrome of diarrhea type, ulcerative colitis, visceral pain or abdominal pain, which contains a compound of the following formula and which has 5-HT7 receptor antagonistic effect or an analogue thereof; and this therapeutic agent has an excellent therapeutic effect and a high safety:
Abstract:
A cut flower preservative slurry composition comprising a water insoluble or hardly soluble cut flower preservative component and a dispersing agent for dispersing the preservative component in water to form a slurry.
Abstract:
The toner for full-color image formation of the invention comprises a binder resin and a colorant, wherein the toner has a volume-average particle diameter of from 3.0 to 9.0 .mu.m and satisfies relationship (1) between the volume-average particle diameter and a colorant content thereof: 11.0/R.ltoreq.C.ltoreq.21.5/R (1) wherein R is 1/2 of the volume-average particle diameter of the toner (.mu.m) and C is the colorant content of the toner (wt %). This toner for full-color image formation is used to conduct development in such a manner that the toner amount transferred to the receiving paper satisfies relationship (2): 0.116R.ltoreq.TMA.ltoreq..ltoreq.0.0223R (2) wherein R is 1/2 of the volume-average particle diameter of the toner (.mu.m) and TMA is the weight of the toner (mg/cm.sup.2) transferred to the receiving paper in a monochromatic solid part thereof.
Abstract translation:本发明的全色图像形成用调色剂包括粘合剂树脂和着色剂,其中调色剂的体积平均粒径为3.0〜9.0μm,并且满足体积平均粒径与 其着色剂含量为:11.0 / R C = 21.5 / R(1)其中R是调色剂的体积平均粒径(μm)的C + E, 调色剂的着色剂含量(重量%)。 用于全色图像形成的这种调色剂用于进行显影,使得转印到接收纸的调色剂量满足关系式(2):0.116R≤TMA = 0.0223R(2)其中 调色剂的体积平均粒径(μm)为R为+ E,(1/2 + EE),TMA为在其单色固体部分中转印到接收纸上的调色剂的重量(mg / cm 2)。
Abstract:
A compound of the formula: ##STR1## wherein Q.sup.1 is CH or N; R is H or C.sub.1 -C.sub.5 alkyl; X is H, halogen, CF.sub.3, or NO.sub.2 ; Y is H or halogen; Z is --O-- or --NH--; A is ##STR2## wherein Q.sup.2, and Q.sup.3 are each CH or N; R.sup.1 and R.sup.2 are each H, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, or C.sub.2 -C.sub.6 alkxoycarobnyl; R.sup.3, R.sup.4, and R.sup.5 are each H or C.sub.1 -C.sub.5 alkyl; R.sup.6 is H, halogen, or C.sub.1 -C.sub.5 alkyl; R.sup.7, R.sup.8, R.sup.9, and R.sup.10 are each H or C.sub.1 -C.sub.5 alkyl; R.sup.11 is H, C.sub.1 -C.sub.5 alkyl, C.sub.1 -C.sub.5 alkoxy, C.sub.2 -C.sub.6 alkenyl, C.sub.6 -C.sub.10 aryl, C.sub.7 -C.sub.15 aryloxyalkyl, or C.sub.7 -C.sub.15 aralkyl; R.sup.12 and R.sup.13 are each H or C.sub.1 -C.sub.5 alkyl; R.sup.14 is C.sub.1 -C.sub.5 alkyl, C.sub.2 -C.sub.6 alkenyl, C.sub.5 -C.sub.10 aryl, or C.sub.7 -C.sub.15 aralkyl; or R.sup.13 and R.sup.14 taken together form C.sub.3 -C.sub.4 alkylene, V.sup.1 and V.sup.2 are each H, halogen, NO.sub.2, CN, or CF.sub.3 ; V.sup.3 is halogen or CF.sub.3 ; W.sup.1 is --O-- or --NH--; W.sup.2 is --(CH.sub.2).sub.n -- wherein n is 0 or 1, or CO; X.sup.1 is halogen, or a salt thereof, which is effective as a herbicidal agent.
Abstract:
A novel depeptide derivative which exhibits inhibitory activity against prolyl endopeptidase and is effective for preventing and curing amnesia is disclosed. A process for chemical synthesis of such a derivative, as well as its use, is also disclosed.
Abstract:
A novel compound that exhibits inhibitory activity against prolyl endopeptidase and a method for chemical synthesis of said compound, as well as its use as a prolyl endopeptidase inhibitor and an anti-amnesic agent that contains said compound as the active ingredient are provided.
Abstract:
N-substituted glutamic acid derivative and salt thereof, a process for production thereof comprising acylation of glutanic acid or derivative thereof, a herbicidal composition comprising the compound, and a method for killing or controlling plants using the compound. The compounds have a selective herbicidal effect.